EU Poison Centre Notifications 2027: Distributors’ Obligations Under Article 45 Of The CLP Regulation

What the 2027 CLP Changes Mean for Distributors, Rebrands, Importers and Chemical Suppliers

Distributors supplying hazardous mixtures in the European Union should prepare for an important clarification of their obligations under Article 45 of the Classification, Labelling and Packaging (CLP) Regulation.

From 1 January 2027, distributors will be explicitly identified as duty holders under Article 45 following amendments introduced through the 2024 revision of the CLP Regulation.

The change is intended to address information gaps that can arise within complex chemical supply chains, particularly where mixtures are supplied in a Member State without an existing poison center notification or where products are rebranded under a distributor’s own name or label.

For distributors, private-label businesses and companies operating across multiple EU markets, this development makes poison center notification (PCN) responsibilities an important part of chemical compliance, product stewardship and supply-chain management.

Businesses should therefore review their product portfolios, supplier arrangements, UFI information, notifications and responsibilities before the 1 January 2027 application date.

Why Poison Centre Notifications Matter

Poison center notifications are designed to provide information that allows poison center’s to respond effectively when people are exposed to hazardous chemical mixtures.

Under the EU CLP framework, companies placing certain hazardous mixtures on the EU market may need to provide information to Member State-appointed bodies for emergency health response purposes.

The information can include:

• Product identification 
• Mixture composition 
• Hazard information 
• Toxicological information 
• Product category 
• Contact details 
• Unique Formula Identifier (UFI), where applicable 

For companies operating through distributors, importers, private-label arrangements or multiple legal entities, maintaining accurate notification information can become challenging.

A product may be manufactured by one company, supplied by another, distributed under a different commercial name and ultimately placed on the market under a distributor's own label.

The 2024 CLP revision provides greater clarity around the responsibilities of distributors in these situations.

What Is Changing From 1 January 2027?

The revised CLP framework explicitly identifies distributors as duty holders under Article 45 in specified circumstances.

The clarification is particularly relevant where a distributor:

1. Sells a mixture in a Member State and the mixture is not covered by an existing notification, or 
2. Rebrands the mixture under its own name or label. 

This means businesses should not automatically assume that the original manufacturer or upstream supplier has completed all necessary poison center notification obligations.

A distributor's role in the supply chain may create its own compliance responsibilities depending on how the mixture is supplied and marketed.

Which Distributors Should Review Their Obligations?

The clarification may be particularly relevant to companies involved in:

Companies should assess the legal role they perform in the supply chain, rather than relying solely on contractual descriptions such as "distributor" or "supplier."

When Does the Change Apply?

The clarified distributor provisions are scheduled to apply from:

1 January 2027

This gives companies time to review their existing compliance systems and determine whether products supplied into EU Member States require additional action.

Businesses should use the transition period to establish which products are already covered by valid poison center notifications and which products may require notification activity.

Early assessment is particularly important for companies supplying the same formulation under different trade names, brands or labels.

Rebranding and Private-Label Products

One of the most important considerations is the treatment of mixtures that are rebranded under a distributor's own name or label.

A distributor may receive a finished chemical mixture from an upstream manufacturer and sell it under its own commercial brand.

In such cases, companies should establish:

• Whether the mixture is hazardous under CLP 
• Whether Article 45 applies 
• Whether an existing PCN covers the product 
• Whether the notification reflects the marketed product identity 
• Whether the UFI is correctly associated with the product 
• Whether Member State requirements are satisfied 
• Whether product or formulation changes affect the notification 

Private-label businesses should therefore treat PCN management as part of their product compliance process rather than as a responsibility that automatically remains with the original manufacturer.

Member State Notification Coverage

Poison center notification requirements operate in the context of the EU market and Member State authorities.

A company should not assume that a notification submitted for one market automatically resolves every compliance question for another Member State.

Distributors should establish where their products are placed on the market and verify whether appropriate notification information has been submitted for the relevant markets.

This is especially important for businesses distributing products across several EU countries.

A structured compliance review should consider:

• Countries of sale 
• Product classification 
• Product identifiers 
• Notification status 
• UFI information 
• Responsible legal entity 
• Language and submission requirements 
• Changes to formulation or product identity 

Supplier and Distributor Data Management

Effective PCN compliance depends heavily on the quality of information moving through the supply chain.

Distributors should establish procedures for obtaining and maintaining relevant information from manufacturers and upstream suppliers.

Supplier controls may include:

• Product composition information
• SDS documentation 
• CLP classification 
• UFI information 
• Existing PCN confirmation 
• Notification references where available 
• Product identifiers 
• Change notifications 
• Updated formulation information
• Regulatory declarations 

Companies should also define contractual responsibilities clearly.

A supplier agreement may specify who prepares a notification, who maintains the information and who manages updates following a formulation or label change.

2027 EU Poison Centre Compliance Readiness Checklist

Impact on Distributors and Importers

The clarification may require distributors to strengthen their internal compliance processes.

Distributors may need to:

• Review hazardous mixture portfolios 
• Identify products lacking notification coverage 
• Assess own-label products 
• Verify supplier information 
• Confirm UFI requirements 
• Review Member State markets 
• Establish notification responsibility 
• Maintain supporting documentation 
• Monitor formulation changes 

Importers and private-label businesses may need to:

• Establish product ownership and responsibility 
• Verify upstream notification arrangements 
• Review imported mixtures 
• Confirm CLP classifications 
• Assess PCN coverage 
• Maintain current regulatory information 

The key objective should be to establish a documented and traceable poison centre notification process before 1 January 2027.

Common Poison Centre Notification Challenges

Businesses may encounter several practical challenges, including:

• Unclear responsibility between manufacturers and distributors 
• Products marketed under multiple names 
• Missing or outdated UFI information 
• Incomplete supplier composition data 
• Changes in formulation 
• Multiple EU markets 
• Legacy products 
• Private-label arrangements 
• Inconsistent regulatory documentation 
• Lack of notification-change procedures 

These challenges can become more significant when businesses operate complex international supply chains.

A centralized product compliance system can help organizations track products, formulations, labels, UFIs, notifications, suppliers and Member State requirements.

Starting this assessment before January 2027 can help businesses identify gaps while there is still time to establish corrective measures.

Frequently Asked Questions

1. What is changing for distributors?

From 1 January 2027, distributors are explicitly identified as duty holders under Article 45 of the CLP Regulation in the relevant circumstances introduced through the 2024 CLP revision.

2. When can distributor obligations become relevant?

The clarification applies where a distributor sells a mixture in a Member State without an existing notification covering it, or where the distributor rebrands the product under its own name or label.

3. Does every distributor need to submit a poison center notification?

The requirement depends on the specific product, circumstances and applicable CLP provisions. Companies should assess their individual role and notification status rather than if every distributor has identical obligations.

4. Are private-label products affected?

Private-label and rebranded hazardous mixtures should be specifically reviewed because the distributor's own name or label can be relevant to Article 45 obligations.

5. Should distributors contact their suppliers?

Yes. Companies should obtain sufficient product, composition, classification, UFI and notification information to establish whether existing notification coverage is adequate.

6. What should companies do before 1 January 2027?

Businesses should review their hazardous mixture portfolios, identify rebranded products, verify existing PCNs and UFIs, map Member State markets and establish clear internal responsibilities.

7. Does the change affect manufacturers?

Manufacturers should also review their distributor arrangements because accurate and accessible product information is important for downstream compliance and notification management.

Conclusion

The clarification of distributors as duty holders under Article 45 of the CLP Regulation from 1 January 2027 represents an important development for companies supplying hazardous mixtures in the EU.

The change is particularly relevant where mixtures are sold in a Member State without existing notification or where products are rebranded under a distributor's own name or label.

For distributors, importers and private-label businesses, poison center compliance should therefore be integrated into broader product stewardship, chemical regulatory and supply-chain management systems.

Companies should use the period before January 2027 to review their product portfolios, notification coverage, UFIs, supplier data and Member State activities.

A proactive and well-documented approach can help organizations identify responsibility gaps and strengthen their EU chemical compliance processes.

How Maven Regulatory Solutions Can Help

Maven Regulatory Solutions can support companies with:

• EU CLP regulatory assessments 
• Poison Centre Notification (PCN) assessments 
• Article 45 compliance reviews 
• UFI assessment and management 
• Hazardous mixture portfolio screening 
• Distributor and importer compliance assessments 
• Private-label and rebranding assessments 
• SDS and classification reviews 
• Supplier compliance assessments
• Member State regulatory assessments 
• Regulatory gap assessments 
• Change-control evaluations 
• Regulatory intelligence and monitoring 

Our approach helps manufacturers, importers and distributors establish practical processes for managing evolving EU CLP and poison center notification requirements.